Constitutive activation of the human bradykinin B2 receptor induced by mutations in transmembrane helices III and VI

Molecular Pharmacology

Volumn 55, Issue 1, 1999, Pages 92-101

  Marie, Jacky ^a   Koch, Caroline ^a   Pruneau, Didier ^b   Paquet, Jean Luc ^b   Groblewski, Thierry ^a   Larguier, RenéE ^a   Lombard, Colette ^a   Deslauriers, BENOÎT ^a   Maigret, Bernard ^c   Bonnafous, Jean Claude ^a  

^a INSERM   (France)

^b Laboratoires Fournier SA   (France)

^c UNIVERSITÉ DE LORRAINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[4 [4 (AMINOIMINOMETHYL)BENZOYL] 1 PIPERAZINYL]CARBONYL] 1 [2,4 DICHLORO 3 [(2,4 DIMETHYL 8 QUINOLINYL)OXYMETHYL]PHENYLSULFONYL]PYRROLIDINE; BRADYKININ B2 RECEPTOR; HELIX LOOP HELIX PROTEIN; ICATIBANT; INOSITOL PHOSPHATE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; DRUG RECEPTOR BINDING; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION;

EID: 0032923919     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.55.1.92     Document Type: Article

References (40)

1. 2 receptor. J Biol Chem 271:27382-27387.
2. 74 of the rat angiotensin II receptor confers changes in antagonist binding affinities and abolishes G-protein coupling. Proc Natl Acad Sci USA 90:5133-5137.
3. 2-adrenergic receptor-G-protein interaction. J Biol Chem 269:29557-29564.
4. Claude PA, Wotta DR, Zhang XH, Prather PL, McGinn TM, Erickson LJ, Loh HH and Law PY (1996) Mutation of a conserved serine in TM4 of opioid receptors confers full agonistic properties to classical antagonists. Proc Natl Acad Sci USA 93:5715-5719.
5. 1 dopamine receptor binding and signal transduction. Mol Pharmacol 50:1338-1345.
6. 296. Biochemistry 31:12592-12601.
7. Dray A and Perkins M (1993) Bradykinin and inflammatory pain. Trends Neurosci 16:99-104.
8. Farrens DL, Altenbach C, Yang K, Hubbell WL and Khorana HG (1996) Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science 274:768-770.
9. 2 bradykinin receptors is adjacent to and discriminates between the C-terminal residues of subtype selective ligands. J Biol Chem 273:12210-12218.
10. Gether U, Ballesteros J. A, Seifert R, Sanders-Bush E, Weinstein H and Kobilka BK (1997a) Structural instability of a constitutively active G protein-coupled receptor. J Biol Chem 272:2587-2590.
11. 2 adrenoreceptor. EMBO J 16:6737-6747.
12. 1A angiotensin II receptor induces its constitutive activation. J Biol Chem 272:1822-1826.
13. Han M, Lin SW, Minkova M, Smith SO and Sakmar TP (1996) Functional interaction of transmembrane helices 3 and 6 in rhodopsin. J Biol Chem 271:32337-32342.
14. Hess JF, Borkowski JA, Young GS, Strader CD and Ransom RW (1992) Cloning and pharmacological characterization of of a human bradykinin (bradykinin-2) receptor. Biochem Biophys Res Commun 184:260-268.
15. 2 bradykinin receptor reveal a different pattern of contacts for peptidic agonists and peptidic antagonists. J Biol Chem 271:28277-28286.
16. 2-adrenergic receptor alters the orientation of its sixth membrane-spanning segment. J Biol Chem 272:18546-18549.
17. Joseph MP, Maigret B, Bonnafous JC, Marie J and Scheraga HA (1995) A computer modeling postulated mechanism for angiotensin II receptor activation. J Prot Chem 14:381-398.
18. Kenakin T (1995) Pharmacological Proteus? Trends Pharmacol Sci 16:256-258.
19. all part of the same energy landscape. Trends Pharmacol Sci 17:190-191.
20. + regulation of agonist binding but does not alter receptor-G protein association. Mol Pharmacol 44:380-384.
21. 2 receptor and its utility for drug design. J Med Chem 37:1347-1354.
22. 2 bradykinin receptors are structurally compatible and involved in discriminating between subtype-selective agonists. J Biol Chem 272:311-317.
23. 2 receptor act as inverse agonists in rat myometrial cells. J Biol Chem 269:25970-25973.
24. Lefkowitz RJ, Cotecchia S, Samama P and Costa T (1993) Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci 14:303-307.
25. 1A angiotensin II receptor is essential for its coupling to phospholipase C. J Biol Chem 269:20815-20818.
26. Nakayana TA and Khorana HG (1990) Orientation of retinal in bovine rhodopsin determined by cross-linking using a photoactivatable analog of 11-cis-retinal. J Biol Chem 265:15762-15769.
27. 2 bradykinin receptor that is essential for high affinity agonist binding. Proc Natl Acad Sci USA 91: 4417-4421.
28. 1 angiotensin receptor is generated by angiotensin II induction. Biochemistry 35:16435-16442.
29. Paquet JL, Baudouin-Legros M, Brunelle G and Meyer P (1990) Angiotensin II-induced proliferation of aortic myocytes in spontaneously hypertensive rats. J Hypertension 8:565-572.
30. Perez DM, Hwa J, Gaivin R, Mathur M, Brown F and Graham RM (1996) Constitutive activation of a single effector pathway: Evidence for multiple activation states of a G protein-coupled receptor. Mol Pharmacol 49:112-122.
31. Proud D and Kaplan AP (1988) Kinin formation: Mechanisms and role in inflammatory disorders. Anna Rev Immunol 6:49-83.
32. 2 receptor. Br J Pharmacol 125:365-372.
33. 2 receptor suppress agonist-independent receptor activation. Biochemistry 35:13368-13377.
34. Regoli D and Barabé J (1980) Pharmacology of bradykinin and related kinins. Pharmocol Rev 32:1-46.
35. 2-adrenergic receptor: Pharmacological creation of a phenotype in transgenic mice. Proc Natl Acad Sci USA 94:137-141.
36. 1B-adrenergic receptor: Role of highly conserved polar amino acids in receptor activation. EMBO J 15:3566-3578.
37. Sheikh S, Zvyaga T, Lichtarge O, Sakmar T and Bourne H (1996) Rhodopsin activation blocked by metal-ion binding sites linking transmembrane helices C and F. Nature 383:347-350.
38. Spalding TA, Burstein ES, Henderson SC, Ducote KR and Brann MR (1998) Identification of a ligand-dependent switch within a muscarinic receptor. J Biol Chem 273:21563-21568.
39. 2-adrenergic receptor promotes partial agonist activity from antagonists. J Biol Chem 264:16470-16477.
40. Wirth K, Hock FJ, Albus U, Linz W, Alpermann HG, Anagnostopoulos H, Henk S, Breipohl G, Konig W, Knolle J and Schölkens BA (1991) Hoe 140: A new potent and long acting bradykinin antagonist: in vivo studies. Br J Pharmacol 102:774-777.